FindTrial
Sign In

Prospective randomized controlled trial of minimally invasive esophagectomy(Ivor-Lewis or McKeown) for esophageal cancer

Prospective randomized controlled trial of minimally invasive esophagectomy(Ivor-Lewis or McKeown) for esophageal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICR-15007285
Enrollment
Unknown
Registered
2015-10-11
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Interventions

Ivor-Lewis:Minimally invasive Ivor-Lewis surgery
McKeown:Minimally invasive McKeown surgery

Sponsors

General Hospital of Chinese Peoples Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Middle and lower esophageal squamous-cell carcinoma confirmed by pathology (distance from the incisor>=25cm); 2. Operation indication is confirmed and there is no operation taboo; 3. Age 18-70 years old; 4. Whole body condition score:0-2; 5. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Simultaneous malignant tumor of other organs; 2. Recurrent esophageal carcinoma; 3. Upper esophageal carcinoma (distance from the incisor<=24cm); 4. Gastric esophagus cannot be conducted.

Design outcomes

Primary

MeasureTime frame
Complication rate;—

Secondary

MeasureTime frame
Recent and long-term survival quality;Progression free survival;—

Countries

China

Contacts

Public ContactXiaobin Hou
drhouxb@163.com+86 13911266969

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026